making sure that the bad actors get weeded out, and that the good actors can continue to do the good work that they're doing. The opportunities ahead: combination therapies In my 50 years in life sciences research, Ive often observed that for every ten people focused on what stands in the way, there is usually only one who can identify the opportunities and inspiration for moving ahead. Richard DiMarchi Distinguished Professor and Gill Chair in Biomolecular Sciences at Indiana University was invited to the workshop to discuss challenges, but he thought it more prudent to focus on opportunities
Available from: Sjstrm L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden , et al
Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use certain GLP-1 medications
The cool thing about glucagon, it's basically making the liver break down glycogen, [which is] stored sugar, Dr
Draw off the clear water
